IHS Chemical Week

EnviroTech :: Biotech

DSM Biologics to Acquire Rhobust Technology from Danish Firm

10:33 PM MDT | May 4, 2010 | Deepti Ramesh

DSM Biologics says it has reached an agreement with biotech company Upfront Chromatography (Copenhagen, Denmark) for the acquisition of the assets and associated business of Rhobust technology for pharmaceutical and other applications. Financial details of the deal were not disclosed. DSM Biologics will gain all rights for the commercialization of Rhobust technology in various fields including the pharmaceutical industry, through the acquisition. “The acquisition of the Rhobust technology is an important addition to the portfolio of DSM Biologics,”...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa